Population
3 patients with hypertension and extensive peripheral vascular disease involving the renal arteries
Design
Case_series
Follow-up
approximately two weeks
Authors
Loading...
Captopril warrants early renal monitoring in hypertensives with possible renovascular disease; leaves open incidence and risk factors pending controlled data.
Captopril therapy may cause severe reversible azotemia in hypertensive patients with underlying renal artery disease.
Steven G. Chrysant (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: